Vol 2, No 2 (April 2013): Translational Lung Cancer Research (Lung Cancer Issue-Guest Editors: Rafael Rosell, Niki Karachaliou)

Editorial

Preface
Rafael Rosell, Niki Karachaliou

Original Article

CK-coated magnetic-based beads as a tool to isolate circulating tumor cells (CTCs) in human tumors
Clara Mayo, Francisco G. Ortega, Ana Giménez-Capitán, Miguel A. Molina-Vila, Maria José Serrano, Santiago Viteri, Carlota Costa, Amaya Gascó, Jordi Bertran-Alamillo, Niki Karachaliou, José Antonio Lorente, Miquel Tarón, Rafael Rosell

Review Articles

ALK and ROS1 as a joint target for the treatment of lung cancer: a review
Raimon Puig de la Bellacasa, Niki Karachaliou, Roger Estrada-Tejedor, Jordi Teixidó, Carlota Costa, José I. Borrell
Comprehensive molecular screening: from the RT-PCR to the RNA-seq
Carlota Costa, Ana Giménez-Capitán, Niki Karachaliou, Rafael Rosell
FGFR1 amplifications in squamous cell carcinomas of the lung: diagnostic and therapeutic implications
Hans-Ulrich Schildhaus, Lucia Nogova, Jürgen Wolf, Reinhard Buettner
Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung
Pedro Mendez, Jose Luis Ramirez
Activated RET and ROS: two new driver mutations in lung adenocarcinoma
Marc Bos, Masyar Gardizi, Hans-Ulrich Schildhaus, Reinhard Buettner, Juergen Wolf
HER2 driven non-small cell lung cancer (NSCLC): potential therapeutic approaches
Ana Christina Garrido-Castro, Enriqueta Felip
Targeting EML4-ALK driven non-small cell lung cancer (NSCLC)
Teresa Morán, Vanesa Quiroga, María de los Llanos Gil, Laia Vilà, Nuria Pardo, Enric Carcereny, Laia Capdevila, Ana M Muñoz-Mármol, Rafael Rosell
KRAS mutant NSCLC, a new opportunity for the synthetic lethality therapeutic approach
Javier de Castro Carpeño, Cristóbal Belda-Iniesta